scholarly journals European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis

Obesity Facts ◽  
2021 ◽  
Vol 14 (2) ◽  
pp. 222-245
Author(s):  
Giovanna Muscogiuri ◽  
Marwan El Ghoch ◽  
Annamaria Colao ◽  
Maria Hassapidou ◽  
Volkan Yumuk ◽  
...  

<b><i>Background:</i></b> The very low-calorie ketogenic diet (VLCKD) has been recently proposed as an appealing nutritional strategy for obesity management. The VLCKD is characterized by a low carbohydrate content (&#x3c;50 g/day), 1–1.5 g of protein/kg of ideal body weight, 15–30 g of fat/day, and a daily intake of about 500–800 calories. <b><i>Objectives:</i></b> The aim of the current document is to suggest a common protocol for VLCKD and to summarize the existing literature on its efficacy in weight management and weight-related comorbidities, as well as the possible side effects. <b><i>Methods:</i></b> This document has been prepared in adherence with Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Literature searches, study selection, methodology development, and quality appraisal were performed independently by 2 authors and the data were collated by means of a meta-analysis and narrative synthesis. <b><i>Results:</i></b> Of the 645 articles retrieved, 15 studies met the inclusion criteria and were reviewed, revealing 4 main findings. First, the VLCKD was shown to result in a significant weight loss in the short, intermediate, and long terms and improvement in body composition parameters as well as glycemic and lipid profiles. Second, when compared with other weight loss interventions of the same duration, the VLCKD showed a major effect on reduction of body weight, fat mass, waist circumference, total cholesterol and triglyceridemia as well as improved insulin resistance. Third, although the VLCKD also resulted in a significant reduction of glycemia, HbA1c, and LDL cholesterol, these changes were similar to those obtained with other weight loss interventions. Finally, the VLCKD can be considered a safe nutritional approach under a health professional’s supervision since the most common side effects are usually clinically mild and easily to manage and recovery is often spontaneous. <b><i>Conclusions:</i></b> The VLCKD can be recommended as an effective dietary treatment for individuals with obesity after considering potential contra-indications and keeping in mind that any dietary treatment has to be personalized. <b><i>Prospero Registry:</i></b> The assessment of the efficacy of VLCKD on body weight, body composition, glycemic and lipid parameters in overweight and obese subjects: a meta-analysis (CRD42020205189).

2020 ◽  
Author(s):  
Heli Lahtio

BACKGROUND Overweight and obesity are major problems worldwide and they lead to an increased risk for several diseases. The use of technology in the treatment of obesity is promising, but there is considerable uncertainty regarding its efficacy in the current literature. OBJECTIVE The aim of this systematic review was to study the effectiveness of technology-based distance weight loss interventions in health care on body composition in comparison to control groups that do not use technology. The aim of the meta-regression was to evaluate the factors associated with the changes in body composition outcomes in a comprehensive PICOS -framework. METHODS Studies were searched from eight databases. The inclusion criteria were developed based on the PICOS-framework (population: 18-65 years; intervention: technology-based distance weight loss interventions; comparison: control groups without technology; outcome: BMI, waist circumference or body fat percentage; study design: randomized controlled trial). Meta-analysis and meta-regression were performed. RESULTS The meta-analysis included 30 studies. The quality of the studies was moderate (7/13). A statistically significant difference was observed in BMI (MD 0.83; 95% CI 0.51 to 1.15; P < .0001), waist circumference (MD 2.45; 95% CI 1.83 to 3.07; P < .0001), and body fat percentage (MD 1.07; 95% CI 0.74 to 1.41; P < .0001) in favor of the weight loss groups using technology. According to the findings of the meta-regression, interventions with personal feedback and higher quality of the studies may have been associated with a reduction in waist circumference and lower body fat percentage. CONCLUSIONS Technology-based distance weight loss interventions significantly reduced BMI, waist circumference, and body fat percentage. Future studies should focus on the comparability of the intervention content but also on the relations between the type of technology, behavioral change models, and biopsychosocial factors. CLINICALTRIAL This systematic review is registered in Prospero (CRD42016035831).


2019 ◽  
Vol 8 (1) ◽  
Author(s):  
Denise Grotto ◽  
Isabella Ferreira Camargo ◽  
Katia Kodaira ◽  
Lauren Giustti Mazzei ◽  
Juliana Castro ◽  
...  

Abstract Background Obesity and its consequences are worldwide epidemic problem; therefore, studies with strategies and mechanisms that favor weight loss to improve outcomes in health are necessary. Effects of mushrooms on body weight are uncertain. The aim of this systematic review is to determine the efficacy of mushrooms in weight loss in animal preclinical models. Method This is a systematic review of preclinical studies of animal models of obesity (any type of non-aquatic mammal), which were exposed to edible and medicinal mushrooms orally in comparison with the control. The following databases will be used: MEDLINE (PubMed), Web of Science, BIOSIS, SCOPUS, and gray literature. There will be no restriction of language, date, or publication status. The primary outcome will be body weight loss. And the secondary outcomes include the total amount of food consumed by the animals, analysis of metabolic parameters, inflammatory mediators, mortality for any causes, and any adverse effect reported. A team of reviewers will select, in pairs and independently, the titles and abstracts, extract data from qualifying studies, and assess bias risk (using SYstematic Review Centre for Laboratory animal Experimentation SYRCLE’s risk of bias tool and the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADES) checklist). The standardized mean difference (SMD) will be calculated to measure treatment effect, with 95% confidence intervals (95% CI). The heterogeneity between-study will be calculated by I2 inconsistency values and Cochran’s Q statistical test, where I2 > 50% and/or p < 0.10 suggest high heterogeneity meta-analyses of random effects will be conducted as possible. Discussion Although many experimental studies about the effects of mushrooms on obesity have already been published, there is still no consensus in the literature. This study will provide evidences of preclinical research on mushrooms and their relation to body weight loss in animal models of obesity, being non-aquatic mammals. Also, this systematic review will show the limitations and strengths of the studies available in the literature, as well as it will to encourage the financing of new studies by public health managers and governmental entities. Systematic review registration PROSPERO (CRD42019125299).


2019 ◽  
Vol 10 ◽  
Author(s):  
Tobias Dünnwald ◽  
Hannes Gatterer ◽  
Martin Faulhaber ◽  
Marjan Arvandi ◽  
Wolfgang Schobersberger

2014 ◽  
Vol 15 (7) ◽  
pp. 610-617 ◽  
Author(s):  
D. Vissers ◽  
H. Neels ◽  
A. Vermandel ◽  
S. De Wachter ◽  
W. A. A. Tjalma ◽  
...  

BMJ ◽  
2017 ◽  
pp. j4849 ◽  
Author(s):  
Chenhan Ma ◽  
Alison Avenell ◽  
Mark Bolland ◽  
Jemma Hudson ◽  
Fiona Stewart ◽  
...  

2015 ◽  
Vol 17 (4) ◽  
pp. 371-378 ◽  
Author(s):  
C. O. Terranova ◽  
C. L. Brakenridge ◽  
S. P. Lawler ◽  
E. G. Eakin ◽  
M. M. Reeves

Sign in / Sign up

Export Citation Format

Share Document